New Delhi: FMCG firm Procter and Gamble (P&G) on Wednesday said it will resume manufacturing and sale of its popular brand 'Vicks Action 500 Extra' after the Delhi High Court stayed government's order banning fixed dose combination drugs.
"The company would resume manufacture and sale of Vicks Action 500 Extra," P&G said in a statement.
The company had discontinued manufacture and sale of Vicks Action 500 Extra.
The government had banned medicines including Vicks Action 500 Extra as part of its decision to stop the manufacture and sale of fixed dose combination drugs (FDCs).
The move was challenged by P&G along with other drug firms before the Delhi High court, which granted stay on it.
"The Delhi High Court granted an interim injunction suspending the operation of the said notification prohibiting for sale and distribution of fixed dose combination drugs till next date of hearing," it added.
Five healthcare majors, including Procter and Gamble, Glenmark and Reckitt Benckiser on Wednesday got interim relief from the Delhi High Court which stayed till March 21 the ban imposed by the government on sale of some of their fixed dose combination (FDC) medicines.
In a gazette notification on March 10, the government had, among others, banned manufacture, sale and distribution of fixed does combination of chlopheniramine maleate plus codiene syrup which is used in the cough syrups.
"The company would resume manufacture and sale of Vicks Action 500 Extra," P&G said in a statement.
The company had discontinued manufacture and sale of Vicks Action 500 Extra.
The government had banned medicines including Vicks Action 500 Extra as part of its decision to stop the manufacture and sale of fixed dose combination drugs (FDCs).
The move was challenged by P&G along with other drug firms before the Delhi High court, which granted stay on it.
"The Delhi High Court granted an interim injunction suspending the operation of the said notification prohibiting for sale and distribution of fixed dose combination drugs till next date of hearing," it added.
Five healthcare majors, including Procter and Gamble, Glenmark and Reckitt Benckiser on Wednesday got interim relief from the Delhi High Court which stayed till March 21 the ban imposed by the government on sale of some of their fixed dose combination (FDC) medicines.
In a gazette notification on March 10, the government had, among others, banned manufacture, sale and distribution of fixed does combination of chlopheniramine maleate plus codiene syrup which is used in the cough syrups.
Track Latest News Live on NDTV.com and get news updates from India and around the world
